CLBX · LONDON STOCK EXCHANGE ·
CelLBxHealth plc
Q3 Trading Update and FY 2026 Outlook
Our AI’s take
CelLBxHealth plc (AIM: CLBX) reported a 60% reduction in cash operating loss to £4.0 million for the nine months ending 30 September 2026, compared to £9.7…
The full digestion is for members. What is good, what is bad and why, the numbers that matter, and the chart, then ask about it by voice or text.
Join freeNew to announcements? Learn what an RNS is and why prices move.